Pneumonia, Community-Acquired
213 results
1 - 100Pneumonia, Community-Acquired
- PATHOGENS
- CLINICAL
- DIAGNOSIS
- TREATMENT
- General considerations
- Outpatient CAP
- Inpatient, non-severe CAP
- Inpatient, severe CAP or risk of drug resistance
- Aspiration pneumonia
- Pathogen specific
- Adjunctive therapy
- Selected Drug Comments
- FOLLOW UP
- OTHER INFORMATION
- Pathogen Specific Therapy
- Basis for recommendation
- References
Pneumonia, bacterial
Ceftibuten
Cefprozil
Pneumonia, Aspiration
Chlamydophila psittaci
Grepafloxacin
Dirithromycin
Telithromycin
Sparfloxacin
Eric Nuermberger, M.D.
Piperacillin + Tazobactam
John G. Bartlett, M.D.
Streptococcus species
Doxycycline
Doxycycline
Clarithromycin
Linezolid
Lefamulin
Omadacycline
Faropenem
Amoxicillin + Clavulanate
Acute Chest Syndrome/Sickle Cell Disease
Legionella species
Respiratory tract infections: In the returned traveler
Acinetobacter baumannii
Chlamydia pneumoniae
Azithromycin
Legionnaires' Disease
Gatifloxacin
Gatifloxacin
Staphylococcus spp.
Cefdinir
Ertapenem
Ceftaroline
Cefditoren
Levofloxacin
Levofloxacin
Haemophilus species
Mycoplasma pneumoniae
Clarithromycin
Moxifloxacin
Moxifloxacin
Azithromycin
Tigecycline
Serratia species
Haemophilus species
Ofloxacin
Severe Acute Respiratory Syndrome [SARS-CoV-1]
Trovafloxacin
Lung Abscess
Cefpodoxime proxetil
Cefoxitin
Empyema and Parapneumonic Effusions
Gemifloxacin
Infectious Diseases and Diabetes
Neisseria meningitidis
Neisseria meningitidis